Green Biologics

Green Biologics Ltd. is a renewable chemicals company focussed on developing and delivering new green alternatives for everyday products. Our core products are renewable n-butanol and acetone. Our technology platform is built on biology and chemistry with core expertise in Clostridium microbial fermentation. We are using our novel technology platform to develop a robust product pipeline, extending the range of green chemicals and applying downstream synthetic chemistry to generate chemical derivatives used in a wide variety of everyday products (paints, coatings, inks, adhesives, textiles, cosmetics, food ingredients, household and industrial cleaners, shampoos and personal care products, fragrances, synthetic rubber, and a myriad of other end uses). Green Biologics is transforming the global chemicals market, providing its customers with products and technology that are more sustainable and higher value than petroleum-based alternatives.
Company Growth (employees)
Type
Private
HQ
Milton, GB
Founded
2003
Size (employees)
75 (est)
Green Biologics was founded in 2003 and is headquartered in Milton, GB

Key People/Management at Green Biologics

Yatin Behl

Yatin Behl

Chemical Process Engineer/ Fermentation Scientist
Tim Staub

Tim Staub

Global VP Business Development
Patrick Simms

Patrick Simms

Global VP, Process Development and Scale Up at Green Biologics, Ltd

Green Biologics Office Locations

Green Biologics has offices in Milton, Columbus and Ashland
Milton, GB (HQ)
Park House Park Dr
Ashland, US
10338 Stony Run Ln
Columbus, US
1130 Gahanna Pkwy
Milton, GB
Park Dr

Green Biologics Financials and Metrics

Summary Metrics

Founding Date

2003

Total Funding

$84.2 m

Latest funding size

$42 m

Time since last funding

almost 3 years

Investors

Green Biologics's latest funding round in January 2015 was reported to be $42 m. In total, Green Biologics has raised $84.2 m

Green Biologics Financials

Green Biologics's revenue was reported to be £30 m in FY, 2015 which is a 1829% increase from the previous period.
GBP

Revenue (FY, 2015)

30 m

Revenue growth (FY, 2014 - FY, 2015), %

1829%

Gross profit (FY, 2015)

1.6 m

Gross profit margin (FY, 2015), %

5%

Net income (FY, 2015)

(13.6 m)

EBITDA (FY, 2015)

(7.8 m)

EBIT (FY, 2015)

(10.7 m)

Cash (31-Dec-2015)

37.6 m
GBPFY, 2007FY, 2014FY, 2015

Revenue

39.1 k1.6 m30 m

Revenue growth, %

1829%

Cost of goods sold

22.4 k1.4 m28.5 m

Gross profit

16.7 k140.7 k1.6 m
GBPFY, 2006FY, 2007FY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015

Cash

109.5 k572.4 k147.1 k784.2 k2.5 m1 m1.2 m10.2 m49.4 m37.6 m

Accounts Receivable

221.6 k235.9 k367.5 k444.8 k475.9 k552 k879.5 k435 k

Inventories

1.1 m979.5 k

Current Assets

139.2 k655.5 k368.6 k1 m2.8 m1.5 m1.7 m10.7 m52.4 m40.5 m
    GBPFY, 2007FY, 2014FY, 2015

    Net Income

    (589.5 k)(7.4 m)(13.6 m)

    Cash From Operating Activities

    (5.2 m)(2.8 m)

    Cash From Financing Activities

    55.1 m(2.4 k)

    Net Change in Cash

    35.7 m(19.8 m)
      GBPY, 2015

      Revenue/Employee

      3.1 m

      Financial Leverage

      1.8 x
      Show all financial metrics

      Green Biologics's Web-traffic and Trends

      Green Biologics Online and Social Media Presence

      Green Biologics Company Life and Culture

      You may also be interested in